(Q34034402)

30 July 2017

title

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route (English)

1 reference

30 July 2017

2

Robert L Atmar

1 reference

30 July 2017

5

Wendy A Keitel

1 reference

30 July 2017

Shital M Patel

1

1 reference

30 July 2017

Hana M El Sahly

series ordinal

3

1 reference

30 July 2017

Thomas R Cate

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

18 November 2009

1 reference

30 July 2017

1 reference

30 July 2017

volume

28

1 reference

30 July 2017

issue

17

1 reference

30 July 2017

page(s)

3025-3029

1 reference

THE ANTIBODY RESPONSE OF HUMAN SUBJECTS VACCINATED WITH THE VIRUS OF HUMAN INFLUENZA.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Reduced-dose influenza vaccine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Antibody responses after dose-sparing intradermal influenza vaccination.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Immunization with Asian-strain influenza vaccine: equivalence of the subcutaneous and intradermal routes

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Immunogenicity and Safety of an Intradermal Boosting Strategy for Vaccination Against Influenza in Lung Transplant Recipients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913582

Serum antibody responses after intradermal vaccination against influenza

29 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.152

Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.152

Dose sparing with intradermal injection of influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.152

Immunologic reactions following the intradermal inoculation of influenza A and B vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.152

[Subcutaneous and intradermal vaccination with Asian influenza vaccine]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.152

Influenza vaccination; a comparison of antibody response obtained by various methods of administration

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19931380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influenza vaccination; comparison of intracutaneous and subcutaneous methods

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19931380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influenza vaccine; a study of serologic responses and incidence of reactions following subcutaneous and intradermal inoculation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19931380

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.10.152

1 reference

30 July 2017

1 reference

30 July 2017

1 reference